Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio Green Med Solution (BGMS) EBITDA (2016 - 2025)

Historic EBITDA for Bio Green Med Solution (BGMS) over the last 17 years, with Q3 2025 value amounting to -$992000.0.

  • Bio Green Med Solution's EBITDA rose 5443.27% to -$992000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.2 million, marking a year-over-year increase of 4095.65%. This contributed to the annual value of -$12.0 million for FY2024, which is 5283.86% up from last year.
  • Latest data reveals that Bio Green Med Solution reported EBITDA of -$992000.0 as of Q3 2025, which was up 5443.27% from -$1.3 million recorded in Q2 2025.
  • In the past 5 years, Bio Green Med Solution's EBITDA ranged from a high of -$992000.0 in Q3 2025 and a low of -$8.8 million during Q4 2022
  • Its 5-year average for EBITDA is -$5.0 million, with a median of -$5.7 million in 2021.
  • Per our database at Business Quant, Bio Green Med Solution's EBITDA tumbled by 14676.38% in 2021 and then surged by 6819.58% in 2024.
  • Bio Green Med Solution's EBITDA (Quarter) stood at -$6.3 million in 2021, then tumbled by 40.87% to -$8.8 million in 2022, then soared by 39.4% to -$5.4 million in 2023, then soared by 65.9% to -$1.8 million in 2024, then skyrocketed by 45.73% to -$992000.0 in 2025.
  • Its EBITDA was -$992000.0 in Q3 2025, compared to -$1.3 million in Q2 2025 and -$5.0 million in Q1 2025.